POPLINE Document Number: 194568
Author(s):
Morroni C
Grams M
Tiezzi L
Westhoff C
Source citation:
Contraception, 2004 Jul;70(1):19-23.
Abstract:
Conventional clinical protocols specify that women initiate depot medroxy progesterone acetate (DMPA) within 7 days of the onset of menses, and product labeling specifies initiation within 5 days. Women outside of this window should wait until next menses to begin, often leaving them with inadequate interim contraceptive protection. An alternative is for women to initiate monthly hormonal contraception immediately, as a bridge to DMPA, with a scheduled follow-up appointment about 4 weeks later. We evaluated bridge preferences and DMPA initiation among 150 women requesting DMPA who were ineligible for their first injection at the time of clinic visit due to menstrual cycle day. Ninety-eight percent (n = 147) rejected the standard protocol of waiting with condoms or abstinence in favor of a hormonal bridge method. Ninety-seven percent follow-up (n = 146) showed that 86% were satisfied with their bridge method. There were no post treatment pregnancies, and 55% (n = 81) of participants had initiated DMPA or another long-term contraceptive within 4 weeks of their initial clinic presentation. (author's)
Keywords:
United StatesIndex page
Research Report
Prospective Studies
Follow-Up Studies
Women
Family Planning Programs
Condom
Counseling
Oral Contraceptives
Medroxyprogesterone Acetate
Injectables
Pregnancy
Developed Countries
North America
Americas
Studies
Research Methodology
Demographic Factors
Population
Family Planning
Programs
Organization and Administration
Barrier Methods
Contraceptive Methods
Contraception
Clinic Activities
Program Activities
Contraceptive Agents, Progestin
Contraceptive Agents, Female
Contraceptive Agents
Reproduction